CurcumaSorb provides the patented Meriva curcumin-phosphatidylcholine complex for enhanced-absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio, promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Meriva than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva per day provided significant benefit in joint comfort, mobility and quality of life.
CurcumaSorb
Supplemental Facts
Amount Per Serving
two vegetarian capsules contain:
meriva® turmeric phytosome
500 mg.
(Curcuma longa extract (root) and sunflower phospholipid complex)
(standardized to contain 18% curcuminoids)
other ingredients: hypoallergenic plant fiber (cellulose), vegetarian capsule (cellulose, water)
Meriva® is a trademark of Indena S.p.A.
Phytosome More Bioavailable® is a trademark of Indena S.p.A.
2 capsules, 1-3 times daily, between meals.